Altop Labs India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.37 Cr
as on 15-11-2024
- Satisfied Charges ₹ 2.15 Cr
as on 15-11-2024
- Revenue 21.97%
(FY 2023)
- Profit 63.66%
(FY 2023)
- Ebitda -2.74%
(FY 2023)
- Net Worth 15.04%
(FY 2023)
- Total Assets 10.66%
(FY 2023)
About Altop Labs India
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.37 Cr. The company has closed loans amounting to ₹2.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Kumar and Shalini Kumar serve as directors at the Company.
- CIN/LLPIN
U24110GJ1992PTC018244
- Company No.
018244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Altop Labs India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Kumar  | Whole-Time Director | 01-Jun-2010 | Current |
| Shalini Kumar | Director | 01-Oct-2014 | Current |
Financial Performance of Altop Labs India.
Altop Labs India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.97% increase. The company also saw a substantial improvement in profitability, with a 63.66% increase in profit. The company's net worth Soared by an impressive increase of 15.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Altop Labs India?
In 2023, Altop Labs India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omni Lifesciences Private LimitedActive 19 years 10 monthsSunil Kumar and Shalini Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Dec 2023 | ₹6.69 M | Open |
Hdfc Bank Limited Creation Date: 11 Oct 2023 | ₹1.45 Cr | Open |
Hdfc Bank Limited Creation Date: 18 May 2021 | ₹2.50 M | Open |
How Many Employees Work at Altop Labs India?
Unlock and access historical data on people associated with Altop Labs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altop Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altop Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
